The	O
Role	O
of	O
TRAF4	B:C1336665
and	O
B3GAT1	O
Gene	O
Expression	I:C0017262
in	O
the	O
Food	O
Hypersensitivity	I:C0016470
and	O
Insect	O
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	O
.	O

The	O
Role	O
of	O
TRAF4	O
and	O
B3GAT1	B:C1412716
Gene	O
Expression	I:C0017262
in	O
the	O
Food	O
Hypersensitivity	I:C0016470
and	O
Insect	O
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	O
.	O

The	O
Role	O
of	O
TRAF4	O
and	O
B3GAT1	O
Gene	B:C0017262
Expression	I:C0017262
in	O
the	O
Food	O
Hypersensitivity	I:C0016470
and	O
Insect	O
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	O
.	O

The	O
Role	O
of	O
TRAF4	O
and	O
B3GAT1	O
Gene	O
Expression	I:C0017262
in	O
the	O
Food	B:C0016470
Hypersensitivity	I:C0016470
and	O
Insect	O
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	O
.	O

The	O
Role	O
of	O
TRAF4	O
and	O
B3GAT1	O
Gene	O
Expression	I:C0017262
in	O
the	O
Food	O
Hypersensitivity	I:C0016470
and	O
Insect	B:C0020517
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	O
.	O

The	O
Role	O
of	O
TRAF4	O
and	O
B3GAT1	O
Gene	O
Expression	I:C0017262
in	O
the	O
Food	O
Hypersensitivity	I:C0016470
and	O
Insect	O
Venom	I:C0020517
Allergy	I:C0020517
in	O
Mastocytosis	B:C0024899
.	O

Mastocytosis	B:C0024899
is	O
an	O
uncommon	O
disease	O
classified	O
as	O
a	O
myeloproliferative	O
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	O
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	O
,	O
hematology	O
and	O
allergology	O
.	O

Mastocytosis	O
is	O
an	O
uncommon	O
disease	B:C0012634
classified	O
as	O
a	O
myeloproliferative	O
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	O
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	O
,	O
hematology	O
and	O
allergology	O
.	O

Mastocytosis	O
is	O
an	O
uncommon	O
disease	O
classified	O
as	O
a	O
myeloproliferative	B:C0027022
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	O
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	O
,	O
hematology	O
and	O
allergology	O
.	O

Mastocytosis	O
is	O
an	O
uncommon	O
disease	O
classified	O
as	O
a	O
myeloproliferative	O
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	B:C1457887
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	O
,	O
hematology	O
and	O
allergology	O
.	O

Mastocytosis	O
is	O
an	O
uncommon	O
disease	O
classified	O
as	O
a	O
myeloproliferative	O
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	O
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	B:C0011627
,	O
hematology	O
and	O
allergology	O
.	O

Mastocytosis	O
is	O
an	O
uncommon	O
disease	O
classified	O
as	O
a	O
myeloproliferative	O
neoplasm	I:C0027022
,	O
however	O
,	O
its	O
symptoms	O
are	O
broad	O
and	O
place	O
patients	O
at	O
crossroads	O
between	O
dermatology	O
,	O
hematology	B:C0018943
and	O
allergology	O
.	O

Patients	O
with	O
mastocytosis	B:C0024899
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	B:C1457887
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	B:C0024880
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	B:C0033774
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	B:C0041834
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	B:C0018681
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	B:C0000729
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	B:C0011991
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	B:C0151825
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	B:C0003864
,	O
hypotension	O
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	B:C0020649
and	O
shock	O
.	O

Patients	O
with	O
mastocytosis	O
often	O
suffer	O
from	O
symptoms	O
resulting	O
from	O
the	O
activation	O
and	O
release	O
of	O
mediators	O
from	O
the	O
mast	O
cells	I:C0024880
,	O
such	O
as	O
generalized	O
itching	O
,	O
redness	O
,	O
headache	O
,	O
abdominal	O
cramps	I:C0000729
,	O
diarrhea	O
,	O
bone	O
pain	I:C0151825
or	O
arthritis	O
,	O
hypotension	O
and	O
shock	B:C0036974
.	O

The	O
possible	O
severe	O
,	O
fatal	O
or	O
near	O
fatal	O
reactions	O
caused	O
by	O
food	B:C0016470
hypersensitivity	I:C0016470
are	O
reasons	O
for	O
the	O
research	O
focused	O
on	O
marker	O
identification	O
.	O

The	O
possible	O
severe	O
,	O
fatal	O
or	O
near	O
fatal	O
reactions	O
caused	O
by	O
food	O
hypersensitivity	I:C0016470
are	O
reasons	O
for	O
the	O
research	O
focused	O
on	O
marker	B:C0005516
identification	O
.	O

The	O
aim	O
of	O
the	O
study	B:C2603343
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	O
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	B:C0017262
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	O
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	B:C0024899
patients	O
with	O
and	O
without	O
food	O
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	B:C0016470
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	O
and	O
drug	B:C0013182
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	O
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	B:C0020517
venom	I:C0020517
allergy	I:C0020517
(	O
insect	O
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

The	O
aim	O
of	O
the	O
study	O
was	O
to	O
analyse	O
the	O
gene	O
expression	I:C0017262
differences	O
in	O
mastocytosis	O
patients	O
with	O
and	O
without	O
food	O
and	O
drug	O
hypersensitivity	I:C0013182
and	O
insect	O
venom	I:C0020517
allergy	I:C0020517
(	O
insect	B:C0020517
venom	I:C0020517
allergy	I:C0020517
)	O
.	O

A	O
total	O
of	O
57	O
Caucasian	B:C0043157
patients	O
with	O
mastocytosis	O
were	O
studied	O
[	O
median	O
age	O
41.8	O
;	O
range	O
18	O
-	O
77	O
years	O
;	O
15	O
(	O
26.3	O
%	O
)	O
males	O
and	O
42	O
(	O
73.7	O
%	O
)	O
females	O
]	O
.	O

A	O
total	O
of	O
57	O
Caucasian	O
patients	O
with	O
mastocytosis	B:C0024899
were	O
studied	O
[	O
median	O
age	O
41.8	O
;	O
range	O
18	O
-	O
77	O
years	O
;	O
15	O
(	O
26.3	O
%	O
)	O
males	O
and	O
42	O
(	O
73.7	O
%	O
)	O
females	O
]	O
.	O

Quantitative	B:C3179034
RT	I:C3179034
-	I:C3179034
PCRs	I:C3179034
of	O
11	O
genes	O
plus	O
ribosomal	O
18S	I:C0035703
RNA	I:C0035703
were	O
run	O
.	O

Quantitative	O
RT	I:C3179034
-	I:C3179034
PCRs	I:C3179034
of	O
11	O
genes	B:C0017337
plus	O
ribosomal	O
18S	I:C0035703
RNA	I:C0035703
were	O
run	O
.	O

Quantitative	O
RT	I:C3179034
-	I:C3179034
PCRs	I:C3179034
of	O
11	O
genes	O
plus	O
ribosomal	B:C0035703
18S	I:C0035703
RNA	I:C0035703
were	O
run	O
.	O

Symptoms	B:C1457887
of	O
food	O
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
(	O
cutaneous	O
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

Symptoms	O
of	O
food	B:C0016470
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
(	O
cutaneous	O
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

Symptoms	O
of	O
food	O
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	B:C1136033
mastocytosis	I:C1136033
(	O
cutaneous	O
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

Symptoms	O
of	O
food	O
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
(	O
cutaneous	B:C1136033
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

Symptoms	O
of	O
food	O
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
(	O
cutaneous	O
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	B:C0272203
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

Symptoms	O
of	O
food	O
hypersensitivity	I:C0016470
were	O
found	O
in	O
12	O
patients	O
(	O
21	O
%	O
)	O
,	O
including	O
3	O
patients	O
(	O
13	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
(	O
cutaneous	O
mastocytosis	I:C1136033
)	O
,	O
and	O
9	O
(	O
28	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
(	O
indolent	B:C0272203
systemic	I:C0272203
mastocytosis	I:C0272203
)	O
.	O

insect	B:C0020517
venom	I:C0020517
allergy	I:C0020517
was	O
confirmed	O
in	O
13	O
patients	O
(	O
22.8	O
%	O
)	O
including	O
6	O
patients	O
(	O
10.5	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
,	O
and	O
7	O
patients	O
(	O
12.3	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
.	O

insect	O
venom	I:C0020517
allergy	I:C0020517
was	O
confirmed	O
in	O
13	O
patients	O
(	O
22.8	O
%	O
)	O
including	O
6	O
patients	O
(	O
10.5	O
%	O
)	O
with	O
cutaneous	B:C1136033
mastocytosis	I:C1136033
,	O
and	O
7	O
patients	O
(	O
12.3	O
%	O
)	O
with	O
indolent	O
systemic	I:C0272203
mastocytosis	I:C0272203
.	O

insect	O
venom	I:C0020517
allergy	I:C0020517
was	O
confirmed	O
in	O
13	O
patients	O
(	O
22.8	O
%	O
)	O
including	O
6	O
patients	O
(	O
10.5	O
%	O
)	O
with	O
cutaneous	O
mastocytosis	I:C1136033
,	O
and	O
7	O
patients	O
(	O
12.3	O
%	O
)	O
with	O
indolent	B:C0272203
systemic	I:C0272203
mastocytosis	I:C0272203
.	O

Drug	B:C0013182
hypersensitivity	I:C0013182
was	O
diagnosed	O
in	O
10	O
patients	O
(	O
17.5	O
%	O
)	O
.	O

Drug	O
hypersensitivity	I:C0013182
was	O
diagnosed	B:C0011900
in	O
10	O
patients	O
(	O
17.5	O
%	O
)	O
.	O

Significant	O
differences	O
in	O
the	O
gene	B:C0017262
expression	I:C0017262
were	O
found	O
for	O
TRAF4	O
(	O
p	O
=	O
0.008	O
)	O
in	O
the	O
comparison	O
of	O
the	O
mastocytosis	O
patients	O
with	O
and	O
without	O
concomitant	O
food	O
hypersensitivity	I:C0016470
.	O

Significant	O
differences	O
in	O
the	O
gene	O
expression	I:C0017262
were	O
found	O
for	O
TRAF4	B:C1336665
(	O
p	O
=	O
0.008	O
)	O
in	O
the	O
comparison	O
of	O
the	O
mastocytosis	O
patients	O
with	O
and	O
without	O
concomitant	O
food	O
hypersensitivity	I:C0016470
.	O

Significant	O
differences	O
in	O
the	O
gene	O
expression	I:C0017262
were	O
found	O
for	O
TRAF4	O
(	O
p	O
=	O
0.008	O
)	O
in	O
the	O
comparison	O
of	O
the	O
mastocytosis	B:C0024899
patients	O
with	O
and	O
without	O
concomitant	O
food	O
hypersensitivity	I:C0016470
.	O

Significant	O
differences	O
in	O
the	O
gene	O
expression	I:C0017262
were	O
found	O
for	O
TRAF4	O
(	O
p	O
=	O
0.008	O
)	O
in	O
the	O
comparison	O
of	O
the	O
mastocytosis	O
patients	O
with	O
and	O
without	O
concomitant	O
food	B:C0016470
hypersensitivity	I:C0016470
.	O

Furthermore	O
significant	O
differences	O
were	O
found	O
in	O
gene	B:C0017262
expression	I:C0017262
for	O
B3GAT1	O
(	O
p	O
=	O
0.003	O
)	O
in	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
compared	O
to	O
patients	O
without	O
insect	O
sting	I:C0079626
anaphylaxis	O
in	O
the	O
medical	O
history	O
.	O

Furthermore	O
significant	O
differences	O
were	O
found	O
in	O
gene	O
expression	I:C0017262
for	O
B3GAT1	B:C1412716
(	O
p	O
=	O
0.003	O
)	O
in	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
compared	O
to	O
patients	O
without	O
insect	O
sting	I:C0079626
anaphylaxis	O
in	O
the	O
medical	O
history	O
.	O

Furthermore	O
significant	O
differences	O
were	O
found	O
in	O
gene	O
expression	I:C0017262
for	O
B3GAT1	O
(	O
p	O
=	O
0.003	O
)	O
in	O
patients	O
with	O
insect	B:C0020517
venom	I:C0020517
allergy	I:C0020517
compared	O
to	O
patients	O
without	O
insect	O
sting	I:C0079626
anaphylaxis	O
in	O
the	O
medical	O
history	O
.	O

Furthermore	O
significant	O
differences	O
were	O
found	O
in	O
gene	O
expression	I:C0017262
for	O
B3GAT1	O
(	O
p	O
=	O
0.003	O
)	O
in	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
compared	O
to	O
patients	O
without	O
insect	B:C0079626
sting	I:C0079626
anaphylaxis	O
in	O
the	O
medical	O
history	O
.	O

Furthermore	O
significant	O
differences	O
were	O
found	O
in	O
gene	O
expression	I:C0017262
for	O
B3GAT1	O
(	O
p	O
=	O
0.003	O
)	O
in	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
compared	O
to	O
patients	O
without	O
insect	O
sting	I:C0079626
anaphylaxis	B:C0002792
in	O
the	O
medical	O
history	O
.	O

The	O
expression	B:C0017262
of	O
studied	O
genes	O
did	O
not	O
differ	O
according	O
to	O
the	O
presence	O
of	O
drug	O
hypersensitivity	I:C0013182
.	O

The	O
expression	O
of	O
studied	O
genes	B:C0017337
did	O
not	O
differ	O
according	O
to	O
the	O
presence	O
of	O
drug	O
hypersensitivity	I:C0013182
.	O

The	O
expression	O
of	O
studied	O
genes	O
did	O
not	O
differ	O
according	O
to	O
the	O
presence	O
of	O
drug	B:C0013182
hypersensitivity	I:C0013182
.	O

The	O
TRAF4	B:C1336665
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	B:C0017262
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	B:C0024899
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	B:C0016470
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	B:C0262926
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	B:C1412716
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	B:C0017262
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	B:C0024899
patients	O
with	O
insect	O
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

The	O
TRAF4	O
expression	O
was	O
higher	O
in	O
mastocytosis	O
patients	O
with	O
food	O
hypersensitivity	I:C0016470
in	O
their	O
medical	O
history	I:C0262926
,	O
the	O
B3GAT1	O
expression	O
was	O
lower	O
in	O
mastocytosis	O
patients	O
with	O
insect	B:C0020517
venom	I:C0020517
allergy	I:C0020517
in	O
history	O
.	O

